MultIceNtre non-intERVentional study for efficacy,safety evaluation of BREZTRI in pts with COPD in RussiA - MINERVA

Study identifier:D5980R00097

ClinicalTrials.gov identifier:NCT06422676

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

Open-label single-arm, non-interventional, multi-centre, cohort study for evaluation of clinical and patient reported outcomes in new users of BREZTRI (Budesonide / Glycopyrronium / Formoterol) in routine care settings

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

4

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 29 Dec 2023
Estimated Primary Completion Date: 31 Dec 2024
Estimated Study Completion Date: 31 Dec 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria